Manufacturing  March 26, 2024

Amgen sues state over price cap law

Drug maker Amgen, the maker of Enbrel, has sued the state because of the Prescription Drug Affordability Board decision to cap the price of the drug.

The Denver Post reported that the drug maker believes that the law permitting the price cap is unconstitutional and conflicts with federal law.

SPONSORED CONTENT

Sign up for BizWest Daily Alerts